merged_cancer-screening-tests-cost.txt
<question_number>1</question_number>
<answer>vastly improved colon cancer treatment</answer>
<question_number>2</question_number>
<answer>studies don't show screening makes people live longer or significantly lowers death rates</answer>
<question_number>3</question_number>
<answer>death rate kept falling at same pace; increased screening did not speed the decline</answer>
<question_number>4</question_number>
<answer>screening’s mortality benefit is so tiny that only very large trials can detect it</answer>
<question_number>5</question_number>
<answer>reflects just a 1-percentage-point absolute risk drop despite 33% relative figure</answer>
<question_number>6</question_number>
<answer>better treatments may drive mortality decline, lessening screening’s perceived benefit</answer>
<question_number>7</question_number>
<answer>dietary changes could lower colon cancer risk and deaths independently of screening</answer>
<question_number>8</question_number>
<answer>huge spending and use of screening despite minimal impact on death rates</answer>
<question_number>9</question_number>
<answer>advocates credit screening for falling deaths while evidence shows decline happened without increased screening impact</answer>
<question_number>10</question_number>
<answer>by citing improved treatments, changing diets, and other exposures as main drivers of falling death rates</answer>